DTC marketing will evolve into a conversation, CEO says

04/23/2012 | Chief Marketer

Direct-to-consumer drug advertising is changing from a linear channel to a conversation that engages patients, although government regulations place some limits on that evolution, says Jay Bolling, CEO of Roska Healthcare. "What you’ll see is an evolution toward multichannel consumer engagement ... across the entire range of the patient journey, from risk assessment, through diagnosis, product trial, and ultimately, brand advocacy based on successful outcomes," he said.

View Full Article in:

Chief Marketer

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations